Haleon PLC Sponsored ADR (NYSE:HLN) Plans Dividend of $0.06

Haleon PLC Sponsored ADR (NYSE:HLN) announced a dividend on Thursday, July 30th. Shareholders of record on Friday, August 14th will be paid a dividend of 0.0642 per share on Thursday, September 17th. This represents a yield of 127.0%. The ex-dividend date of this dividend is Friday, August 14th.

Haleon has a payout ratio of 46.3% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Haleon to earn $0.60 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 41.7%.

Haleon Stock Down 1.7%

Haleon stock opened at $10.11 on Friday. Haleon has a fifty-two week low of $8.65 and a fifty-two week high of $11.28. The company has a market cap of $44.51 billion, a PE ratio of 25.91, a PEG ratio of 2.38 and a beta of 0.13. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92. The business’s 50-day simple moving average is $9.43 and its two-hundred day simple moving average is $9.85.

Wall Street Analyst Weigh In

HLN has been the subject of a number of recent research reports. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Zacks Research cut shares of Haleon from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Finally, Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Haleon currently has an average rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.